Patent · US Active

Identification of surface associated antigen FLJ31461 for tumor diagnosis and therapy

US10724103B2 · kind B2 · utility

1Cited by
4References
3Claims
0Family size

Inventors

Key dates

Filing dateAug 11, 2017
Grant dateJul 28, 2020
Priority date
Expiry dateSep 21, 2037

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N33/53
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to the identification of gene products that are the result of tumor-associated expression and the nucleic acids encoding the same. The invention also relates to the therapy and diagnosis of diseases wherein these gene products are the result of an aberrant tumor-associated expression. The invention also relates to the proteins, polypeptides and peptides that are the result of tumor-associated expression and to the nucleic acids encoding the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.